| Date | News |
| 08 May 2012 | Actelion presents its strategy for value creation |
| 04 May 2012 | The Actelion Annual General Meeting 2012 took place on Friday 04 May 2012 at 10:00 CET, at the Congress Center, Messe Basel, Switzerland. |
| 30 April 2012 | Actelion's macitentan meets primary endpoint in pivotal Phase III SERAPHIN outcome study in patients with pulmonary arterial hypertension. |
